The Delusions of Grandeur in Tobacco Control
There’s a particular kind of certainty that creeps into institutions that believe they’ve already won.
Tobacco control, in many parts of the world, is no longer just a public health effort. It has become a moral crusade wrapped in the language of science. And like all crusades that outlive their original battlefield, it risks drifting into something far less grounded: a belief in its own infallibility.
At its best, tobacco control was one of the greatest public health successes of the modern era. Smoking rates fell, awareness grew, and the harms of combustible tobacco became undeniable. That success, however, may have planted the seeds of a deeper problem, a quiet, creeping delusion of grandeur.
Because once you believe you’ve saved the world, you start to think you can do no wrong.
That’s where the fracture begins, and it helps explain the hostility toward tobacco harm reduction.
Tobacco harm reduction rests on a simple premise. People use nicotine, but it’s the smoke that causes the overwhelming burden of disease. Remove combustion, and you dramatically reduce harm. This isn’t a radical idea. Public health has applied the same logic to countless other areas. When people can’t or won’t stop a behaviour, you make that behaviour safer.
Yet in tobacco control, that logic is increasingly rejected.
The reason is not purely scientific. Harm reduction does not demand abstinence. It accepts that people will continue to use nicotine and works within that reality. For a system that has shifted toward eliminating nicotine use, that is deeply uncomfortable.
Harm reduction doesn’t just offer an alternative. It exposes a contradiction. If smokers can switch to lower-risk products and significantly reduce harm, then the long-standing framing of nicotine as the central villain begins to unravel. And once that distinction becomes clear, the simplicity of the existing narrative starts to break down.
That loss of simplicity matters more than many are willing to admit.
Much of modern tobacco control relies on clear, uncompromising messaging. All nicotine is bad. All use is undesirable. The goal is total cessation. Harm reduction complicates that. It introduces nuance. It asks people to think in terms of relative risk rather than absolute prohibition.
And nuance is harder to control.
At its core, opposition to harm reduction often reflects a deeper discomfort with losing control. Harm reduction shifts the agency back to individuals rather than institutions. It allows people to make their own decisions about risk, even if those decisions do not align with an abstinence-only ideal.
For systems built on regulation and behavioural engineering, that is a fundamental shift.
There is also a symbolic dimension that is rarely acknowledged openly. The appearance of smoking has long been treated as something that must be eradicated, not just the harm itself. Harm reduction disrupts that. It allows behaviours that look similar to smoking to persist, even if the risk is dramatically lower. For some, that is seen as a step backward, regardless of the health outcomes.
Institutional inertia also plays a role. Entire frameworks, careers, and reputations have been built on a model that treats all nicotine use as inherently problematic. Harm reduction challenges that foundation. It raises uncomfortable questions about whether the end goal should be nicotine-free or simply smoke-free. It asks whether success should be measured by behaviour or by health outcomes.
These are not easy questions for any system to absorb.
There is also a tendency to fall back on precaution, but often in a way that ignores context. No nicotine product is completely risk-free. But the relevant comparison has always been with smoking. When that comparison is set aside, precaution becomes a barrier rather than a safeguard, and the most harmful form of nicotine use remains dominant by default.
Underneath all of this sits a moral shift. Nicotine use is no longer framed purely as a health issue but as a reflection of personal failure. Abstinence becomes a virtue, and continued use, even in reduced-risk forms, becomes something to be corrected. That framing leaves little room for harm reduction, because harm reduction accepts people as they are rather than as they are expected to be.
The consequences of this resistance are not theoretical. They show up in smokers who might have switched but didn’t, in policies that restrict access to lower-risk alternatives, in the growth of illicit markets, and in widespread confusion about relative risk.
Most importantly, they show up in missed opportunities to reduce disease and death.
Tobacco control now faces a choice, whether to continue defending a model built on certainty and control, or to return to a more grounded approach focused on outcomes. That would mean accepting complexity, acknowledging uncertainty, and prioritising reductions in harm over the pursuit of ideological purity.
The original goal was never perfection. It was to reduce the damage caused by smoking
If harm reduction can accelerate that, then resisting it is not caution. It is something closer to denial.
And denial, especially when backed by certainty, is where delusions of grandeur take hold.


Harm reduction for people who inject drugs suddenly became a huge issue across the world when the serious threat of HIV began to be appreciated in the 1980s. Most of the population never had male-to-male sex and never injected drugs. If HIV became established in large numbers in this large population, regaining HIV control would be extremely difficult, extremely expensive and take a long time. The greatest risk of a significant spread of HIV in this low-risk population was substantial spread of HIV among the high risk population of people who inject drugs. To prevent that from happening, communities had to provide explicit education about HIV risks in a way that was going to be accepted by people who inject drugs, methadone treatment for people injecting street heroin, and encourage the establishment of organisations run for people who inject drugs run by people who inject drugs. This ambitious programme was vigorously resisted but was achieved in over 80 countries in the world. Methadone for heroin users is much the same as vaping or other safer, smoke-free options for people who smoke cigarettes. Initially, many clinicians involved in methadone treatment used the lowest dose for the shortest period they thought they could get away with. But gradually they came to realise that using a low dose and ending methadone treatment when the clinician felt like it brought terrible outcomes for their patients and communities. Tobacco control today is like the opponents of methadone and needle syringe programs decades ago. The World Health Organisation opposed needle syringe programs then and opposes safer, smoke-free nicotine options today.
Fucking awesome stack. Wish my pen flowed like yours. Tremendous explanation of antz behavior and ignorance. It's our way or no way but that no longer works. It's not just save the snot gobblers, save the adults using thr tools